Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	9.37	10.81	9.24	27.38	5.54	34.83
Short-Term Investments	44.43	91.38	159.64	158.84	17.3	-
Cash & Short-Term Investments	53.8	102.19	168.89	186.22	22.84	34.83
Cash Growth	-55.06%	-39.49%	-9.31%	715.39%	-34.42%	155.43%
Other Receivables	0.43	1.3	-	-	-	0.3
Receivables	0.43	1.3	-	-	-	0.3
Prepaid Expenses	2.13	2.04	3.86	2.94	2.52	0.77
Other Current Assets	-	0.18	-	-	-	-
Total Current Assets	57.15	105.71	172.75	189.16	25.36	35.9
Property, Plant & Equipment	20.32	24.08	28.53	30.6	16.35	11.52
Long-Term Investments	30.6	26.41	23.94	85.35	-	-
Long-Term Deferred Charges	-	0.37	-	-	2.36	-
Other Long-Term Assets	1.27	3.22	2.59	2.61	2.47	1.03
Total Assets	109.33	159.78	227.81	307.72	46.54	48.45
Accounts Payable	1.48	2.99	3.59	3.57	1.6	2.1
Accrued Expenses	10.43	12.49	15.14	12.38	6.66	2.87
Current Portion of Leases	2.82	2.78	2.39	2.5	1.5	3.1
Current Unearned Revenue	1.97	2.2	1.99	2.87	1.5	0.6
Total Current Liabilities	18.08	20.46	23.12	21.33	11.26	8.66
Long-Term Leases	15.35	17.44	20.22	21.85	9.38	7.09
Long-Term Unearned Revenue	3.87	9.11	12.92	14.21	-	0.97
Other Long-Term Liabilities	-	0.04	0.04	0.21	0.33	0.07
Total Liabilities	37.3	47.04	56.3	57.6	20.97	16.79
Common Stock	0	0	-	-	-	-
Additional Paid-In Capital	483.29	476.99	467.51	457.43	3.45	1.83
Retained Earnings	-411.47	-364.29	-295.09	-206.99	-108.4	-47.67
Comprehensive Income & Other	0.21	0.04	-0.92	-0.32	-	-
Total Common Equity	72.03	112.74	171.51	250.12	-104.95	-45.85
Shareholders' Equity	72.03	112.74	171.51	250.12	25.57	31.66
Total Liabilities & Equity	109.33	159.78	227.81	307.72	46.54	48.45
Total Debt	18.18	20.22	22.61	24.36	10.88	10.19
Net Cash (Debt)	35.62	81.97	146.28	161.86	11.96	24.64
Net Cash Growth	-63.97%	-43.96%	-9.63%	1253.26%	-51.46%	81.26%
Net Cash Per Share	0.93	2.17	3.92	4.88	5.69	12.36
Filing Date Shares Outstanding	38.27	38.13	37.81	37.47	36.33	1.92
Total Common Shares Outstanding	38.27	38.11	37.8	37.4	2.13	1.92
Working Capital	39.06	85.25	149.63	167.83	14.1	27.24
Book Value Per Share	1.88	2.96	4.54	6.69	-49.27	-23.86
Tangible Book Value	72.03	112.74	171.51	250.12	-104.95	-45.85
Tangible Book Value Per Share	1.88	2.96	4.54	6.69	-49.27	-23.86
Machinery	10.13	10.42	10.1	8.26	5.32	2.03
Leasehold Improvements	0.29	0.29	0.27	0.15	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.